Tectonic Therapeutic, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$84.0M | -$58.0M | -$44.6M | -$105.4M | -$118.8M |
| Operating expenses | $84.0M | $58.0M | $44.6M | $105.4M | $118.8M |
| Cash from operations | -$60.1M | -$59.1M | -$40.7M | -$97.2M | -$98.0M |
| Capital expenditure | $208,000 | $156,000 | $279,000 | $267,000 | $2.5M |
| Free cash flow | -$60.3M | -$59.2M | -$41.0M | -$97.5M | -$100.5M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $261.0M | $152.9M | $39.4M | $103.9M | $203.8M |
| Total liabilities | $9.7M | $12.1M | $43.4M | $28.6M | $34.4M |
| Total debt | — | — | — | $16.4M | $16.4M |
Shares outstanding 18.9M · Free float 49.2%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.